The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.
Silver - Individuals: litigation
Devastatingly effective in trials and at the Federal Circuit and Supreme Court, WilmerHale is the perfect partner for big-ticket patent litigation. It draws astutely on its resources – it is abundant in trial lawyers, appellate specialists and technical experts – to configure the optimum team for each case, ensuring it can hit the ground running and pursue the most effective strategies. Its DC lawyers are front and centre of many high-profile briefs: as an example, William McElwain was key to recent back-to-back Federal Circuit victories on behalf of Becton, Dickinson and Company and Roche against Enzo Life Sciences, in which the court unanimously affirmed a rare summary judgment ruling in the District of Delaware which invalidated the key patent asserted against his clients. David Cavanaugh and Gregory Lantier, meanwhile, obtained WilmerHale’s first final written decision in a post-grant review proceeding, on behalf of GMG Products, invalidating certain claims of a patent owned by competitor Traeger Pellet Grills. Both lawyers are recommended in the IAM Patent 1000’s national post-grant table, on which Cavanaugh – a veteran of over 250 inter partes reviews – is one among just 10 individuals. On the life sciences side, Amy Kreiger Wigmore is in the thick of things and has satisfying recent results to show for her efforts. Together with Bill Lee, she obtained a trial win for Bristol-Myers Squibb and Pfizer in litigation concerning their blockbuster Eliquis drug used to treat and reduce the risk of blood clots and the risk of stroke; initially filed against 25 different generic drug companies, the case started out as one of the largest Hatch-Waxman litigations ever. Seth Waxman is WilmerHale’s Supreme Court and appellate supremo and has been vital in cementing many of the group’s wins.